Prakiraan pendapatan perusahaan: AEON Biopharma Inc. (AEON)

AEON Biopharma develops botulinum toxins for migraine therapy, merging aesthetics and medicine to minimize risks. The development of treatments for muscular pathologies allows the brand to secure a stable niche in neurology. The projected sales volume dynamics visualize this potential, where 0.00 determines this parameter level. However, a high dependence on the verdict of US regulators maintains the risks of a binary development model.

Volume dodolan sing dikarepake perusahaan: AEON Biopharma (AEON) kanggo 21.02.2024 - 15.11.2026

Ringkesan rincian data analitis AEON Biopharma (AEON)

- nilai saham lan prakiraan konsensus rega:

Bagan rega AEON Biopharma|AEON - Rata-rata rega prakiraan

- indikator kapitalisasi bursa perusahaan:

Nilai pasar AEON Biopharma|AEON - Nilai Total Perusahaan

- data ekuitas miturut neraca:

Aset Bersih saben Siji Saham AEON Biopharma|AEON - Ekuitas Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku aeonbiopharma.com|AEON - Aset Neraca Perusahaan

- statistik kawajiban utang lan likuiditas:

Rasio Total Utang marang Ekuitas AEON Biopharma|AEON - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal aeonbiopharma.com|AEON - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku AEON Biopharma Inc.|AEON - Utang jangka dawa|Utang jangka cendhak perusahaan AEON Biopharma|Likuiditas cepet aeonbiopharma.com

- indikator profitabilitas perusahaan lan kelipatan valuasi:

AEON - Bathi perusahaan|Bathi mangsa ngarep AEON Biopharma|AEON - Nilai perusahaan marang bathi resik|Pangali Forward P/E AEON Biopharma, Inc.|AEON - Rasio rega marang bathi tumrap wutah|Pangali EV/EBITDA AEON Biopharma, Inc.|AEON - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan AEON Biopharma|AEON - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan aeonbiopharma.com|AEON - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep AEON Biopharma

- data dodolan lan asil:

AEON - Pendapatan dodolan perusahaan|Prakiraan volume dodolan aeonbiopharma.com|AEON - Multiplikator P/S|Rasio rega marang prakiraan pendapatan AEON Biopharma|AEON - Dinamika pendapatan YoY sajrone rolas wulan kepungkur

Analisis komprehensif perusahaan:AEON Biopharma, Inc.

This indicator determines the fair value of an asset by discounting its long-term prospects. The calculation is based on stripping cash flows of commodity price volatility and logistics costs. By analyzing the company's projected future revenue, an investor identifies the stability of the fundamental trend. For AEON Biopharma (AEON), this metric reflects the expansion potential of its migraine medications. An increase in this indicator confirms successful competition with leaders in the neurological market.

Pesaing AEON Biopharma (AEON)

Prakiraan pendapatan perusahaan Jazz Pharmaceuticals Corp (JAZZ)|CYTK - Volume dodolan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan PTC Therapeutics Corp PTCT|Scholar Rock Inc. - Prakiraan pendapatan perusahaan|CNTA - Prakiraan pendapatan perusahaan|Prakiraan dodolan perusahaan Dyne Therapeutics (DYN)|EWTX: Prakiraan volume dodolan|Prakiraan dodolan perusahaan Rapport Pharma RAPP|Volume dodolan mangsa ngarep perusahaan ALMS|Volume dodolan sing dikarepake perusahaan Zevra Therapeutics ZVRA|Prakiraan volume dodolan CTNM|Prakiraan pendapatan perusahaan LRMR (Larimar Therapeutics)|Prakiraan volume dodolan CAPR (Capricor Therapeutics Inc.)|TRDA: Prakiraan pendapatan perusahaan|Channel Therapeutics Inc. - Prakiraan volume dodolan|MNOV (medicinova.com) - Prakiraan pendapatan perusahaan|Serina Therapeutics (SER) - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan BTAI|Prakiraan pendapatan perusahaan ProMIS Neurosciences, Inc.|Volume dodolan sing dikarepake perusahaan Apimeds Pharmaceuticals APUS|Prakiraan volume dodolan NLSP|Volume dodolan mangsa ngarep perusahaan Bionomics BNOX|Prakiraan volume dodolan HUGE (fsdpharma.com)|RETA (Reata Pharmaceuticals) - Pendapatan sing dikarepake perusahaan